A mitochondrial protein's protective role offers new hope for Charcot-Marie-Tooth disease
Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, ...
FierceBiotech11h
Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...
hemophilianewstoday7h
After 4 years, hemophilia B bleeding rates remain low with Hemgenix
Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...